Grigore T. Popa University Of Medicine And Pharmacy
Clinical trials sponsored by Grigore T. Popa University Of Medicine And Pharmacy, explained in plain language.
-
Can common diabetes drugs help protect hearts and kidneys?
Disease control Recruiting nowThis study aims to understand how a class of drugs called SGLT2 inhibitors affects the long-term health of people who have both chronic kidney disease and a specific type of heart failure (HFpEF). Researchers will observe 200 patients, some taking the drug and some not, to see if…
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New test could spare liver patients unnecessary transfusions
Disease control Recruiting nowThis study is testing if a special blood test (called ROTEM) can better guide doctors on when liver cirrhosis patients need a transfusion before a risky medical procedure. Currently, many patients get transfusions based on standard tests, but this might not always be necessary. R…
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Anesthesia choice may protect muscles during cancer surgery
Disease control Recruiting nowThis study aims to see if the type of anesthesia used during colorectal cancer surgery affects how much muscle mass patients lose afterward. Researchers will compare two common anesthesia methods in 40 patients to determine which one better preserves muscle strength and size. The…
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC